Janumet 50mg/850mg Film-Coated Tablet
Country: Filippini
Lingwa: Ingliż
Sors: FDA (Food And Drug Administration)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Sitagliptin (as Monohydrate Phosphate) , Metformin Hydrochloride
Disponibbli minn:
Merck Sharp & Dogme (I.A.) LLC; Distributor: Merck Sharp & Dogme (I.A.) LLC
INN (Isem Internazzjonali):
Sitagliptin (as Monohydrate Phosphate) + Metformin Hydrochloride
Dożaġġ:
50mg/850mg
Għamla farmaċewtika:
Film-Coated Tablet
Unitajiet fil-pakkett:
Alu-Alu Blister pack x 7's (Box of 28's) / Blister pack of 7 by 1's (as physician's sample), Alu/Alu blister pack x 7's (box of
Manifatturat minn:
Patheon Puerto Rico, Inc., U.S.A.
Data ta 'l-awtorizzazzjoni:
2024-02-29
